Zurich, Switzerland, December 03, 2025 - MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive ...

BALTIMORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA) and the Urology Care Foundation (UCF) have announced the first two awardees of the UCF Bridge Award ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

The global surgical robotics market is forecast to grow at a compound annual growth rate (CAGR) of 15% between 2025 and 2030.

US FDA approves Cleveland Diagnostics’ novel blood-based prostate cancer test, IsoPSA: Cleveland Tuesday, December 2, 2025, 17:00 Hrs [IST] Cleveland Diagnostics, Inc., a pionee ...

The optimal time to measure PSA response to treatment is the one that best predicts metastatic hormone-sensitive prostate cancer (mHSPC) progression.

Simultaneous penile prosthesis during prostatectomy improves satisfaction and preserves length without added risk. Learn more ...

Find out how smoking and hysterectomy increase vaginal mesh erosion risk in POP (pelvic organ prolapse) surgery. Learn more.

IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade Prostate Cancer ...

Interviews with patients revealed that sexual health discussions are a vital part of overall cancer care for women with gynecologic cancers. Women who underwent treatment for gynecologic cancer ...

Robotic surgery has become a leading option for various surgical procedures in recent years, both malignant and benign.